Announced
Completed
Synopsis
Lantheus, a radiopharmaceutical-focused company, completed the acquisition of Life Molecular Imaging, a radiopharmaceutical company, from Life Healthcare, a private healthcare provider, for $780m. "This acquisition aligns with our strategy to drive long-term growth and value creation by investing in high-potential, complementary assets and R&D capabilities to strengthen our radiopharmaceutical leadership," Brian Markison, Lantheus CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite
Seller Team (3)
Bidder Team (9)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy